Elicio Therapeutics (ELTX) Shares Outstanding (2020 - 2026)

Elicio Therapeutics (ELTX) has 7 years of Shares Outstanding data on file, last reported at $18.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 16.62% year-over-year to $18.6 million; the trailing twelve-month figure through Mar 2026 stood at $18.6 million (up 16.62% YoY), and the FY2025 full-year result was $17.8 million, up 61.18% from the prior year.
• Shares Outstanding for Q1 2026 stood at $18.6 million, up from $17.8 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $18.6 million in Q1 2026 and bottomed at $313046.0 in Q1 2022.
• The 5-year median for Shares Outstanding is $10.2 million (2024), against an average of $9.2 million.
• The widest annual swing landed in 2022, when Shares Outstanding tumbled 98.95%; it then soared 3019.84% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $320281.0 in 2022, then jumped by 2903.04% to $9.6 million in 2023, then climbed by 14.82% to $11.0 million in 2024, then surged by 61.18% to $17.8 million in 2025, then advanced by 4.72% to $18.6 million in 2026.
• The last three Shares Outstanding figures came in at $18.6 million (Q1 2026), $17.8 million (Q4 2025), and $17.3 million (Q3 2025), per Business Quant data.

Peer Comparison